This year, our International Congress is the “First Conference on Integrative Oncology-Istituto Superiore di Sanità-ARTOI: The Translational Medicine- from the laboratory to the Clinic evidence.”
DOWNLOAD FORM for abstract (DEADLINE EXTENDED TO 20 SEPTEMBER 2013)
It’s possible the vision in live Streaming, BOOK for STREAMING
The event is organized by the ISS (National Health Institute) and ARTOI. The Conference venue will be at the Istituto Superiore di Sanità “Aula Pocchiari”.
This year’s Conference is about clinical interest and research: drugs low-dose, acupuncture and phytotherapy studied for their application in the field of oncology.
The international and Italian Speakers, all high- scientific and professional profile for this matter, will contribute to the realization of a unique event in Italy: integration in Oncology.
Also in Italy we have excellent specialists in scientific oncology research, and the National Institute of Health is an example. The cancer research workers are giving appropriate responses to patients’ needs: better quality of life and personalized therapies. ARTOI is considered a valuable partner.
The well-being during cancer treatments and prevention of neoplastic diseases are our main points. This year there will be the opportunity to present scientific works even outside the relationship theme: a poster session. The best scientific works will be presented orally in plenary session.
The Conference will have some “previews” in the field of prevention and wellness: the pap-breast. In the field of integrative treatments: the Synchrotron.
We wait for you on 6 and 7 November 2013 in Rome.
Massimo Bonucci – President of ARTOI
Il 25 febbraio a Genova , presso la sala corsi del Centro 3+1 di Genova corso Paganini 35/1si terrà una giornata dedicata agli aggiornamenti sull’oncologia integrata. Interverrà, fra gli altri, anche il prof. Massimo Bonucci,
Roma – 10 marzo 2012 – Università Salesiana Aula Paolo VI – P.zza dell’Ateneo Salesiano 1
“L’immagine della salute”, organizzato da Frontis
Pubblichiamo la locandina del Seminario di: Europe AHCC Research Association (EARA)
L’evento si terrà il 23 maggio 2012 alle 15 e 30 a Ginevra, presso il PalaExpo, Padiglione G
Interverrà anche il nostro Prof. Massimo Bonucci.
21-22 September 2012 Palazzo dei Congressi, Florence
The Future of Comprehensive Patient Care
Rome, Istituto Superiore di Sanità – Viale Regina Elena, 299 – October 10-13, 2011
Department of Technology and Health – ISS Institute of Chemical Methodologies – CNR
Rome, 21 October 2011 Centro Congressi Palazzo Rospigliosi
The integrative treatment of lung cancer
Rome, from 2 to 3 December 2011 – Chamber of Deputies
3rd International Conference on Integrative Oncology Therapy Research
Cleveland, Ohio, USA november 10-12, 2011 – InterContinental Hotel
Conferenza internazionale della Society for Integrative Oncology
Buenos Aires City June 24-25, 2011 CEMIC University Hospital – Saavedra Center
“Integrating Complementary Therapies in the Care of Cancer Patients and their Families”
Integrative Oncology: challenges and international results.
Biointegrative medicine is a scientific reality, with its aims and achievements. The international realities of its use are also evident in the cancer field, where at this time, however, Italy seems not to have a major role. It must cover the cultural gap. The Association ARTOI was founded with this purpose.
Rome 14/12/2010 – National Institute of Health
Cancer therapy: use of natural drugs in Oncology
The evolution of phytotherapeutic medicine is such that its use in oncology is faced with scientific accuracy.
Rome 20/11/2010 – Sala delle Colonne- University “G. Marconi “
New paradigm for cancer
The cancer scenery is very complex. It needs clarity on those which may be the results of the standard treatments and not. The new frontier of cancer stem cells, with their recognition and treatment, could revolutionize the concept so far had on the development of neoplasia. A round table tries to develop the concept.
Rome 19/11/2010 – Chamber of Deputies
From Research to Therapy
Still further are the results of the combined use of traditional treatments. The approach of basic research is important to give credibility to the integrative therapy. New frontiers open to fight cancer.
READ THE ABSTRACTS OF INTERVENTION:
Rome 08/08/2010 – National Institute of Health
Use of natural drugs in oncology
Phytotherapy has always had an important role in the treatment of diseases. The study of the active principle has contributed to an increasing use in the field of neoplastic pathologies, not only for a reduction in side effects but also in treating and preventing cancer.
Integrative Cancer Therapy
The colorectal cancer is a leading cause of death for neoplastic disease. Standard treatments have shown promising results when they were used in combination. New treatment approaches are occurring on the clinical scene. The integrative cancer therapy aims to help to better understand this concept.
Roma 12/12/2009 – Camera dei Deputati
Lotta contro i tumori e le cellule staminali neoplastiche
La battaglia contro la neoplasia non è stata ancora vinta. Nuove scoperte sono all’orizzonte e dobbiamo riuscire a comprenderle e metterle in pratica. Un nuovo approccio sono le terapie integrate e la scoperta delle cellule staminali neoplastiche. Bisogna conoscere quali possono essere le strategie migliori per vincere.
LEGGI GLI ABSTRACT:
Terapia Ortomolecolare del Dr. Nieper: Approccio metodologico in corso di trattamento oncologico
Il Dr. Nieper, già Presidente della Società di Oncologia in Germania, è stato uno dei precursori della terapia complementare in Oncologia. I suoi insegnamenti sono la base della terapia integrata attuale. La prevenzione è stato uno dei suoi fondamenti nella lotta contro le neoplasie.
Rotary Club “Castiglioncello-Colline Pisane” Castiglioncello 24/10/2008
Conferenza tenuta dal Dr. Massimo Bonucci: Nuove strategie e conoscenze
La prevenzione deve essere considerata la prima nostra difesa contro la patologia neoplastica. Essa svolge un ruolo di primo piano nella lotta contro lo sviluppo nella malattia cancerosa.